Skip to main content
. 2022 Jun 27;11(13):3705. doi: 10.3390/jcm11133705

Table 2.

Demographic information of persistent and recurrent patients.

Persistent
(n = 23)
Recurrence
(n = 13)
ap Value
Gender, n (%) 0.682
 Female 17 (73.9) 11 (84.6)
 Male 6 (26.1) 2 (15.4)
Age (year) ± SE (range) 57.6 ± 2.3 (34–77) 61.9 ± 1.2 (55–69) 0.281
BH (cm) ± SE (range) 158.6 ± 0.9 (150–170) 155.9 ± 2.3 (148–174) 0.006
BW (kg) ± SE (range) 62.7 ± 1.6 (46–75) 62.5 ± 4.7 (45–93) 0.361
DM (%) 6 (26.1) 4 (30.8) 0.763
Hypertension (%) 4 (17.4) 4 (30.8) 0.422
Lesion site, n (%) 0.731
 Left 11 (47.8) 5 (38.5)
 Right 12 (52.2) 8 (61.5)
Duration (month) ± SE (range) 17.0 ± 3.3 (1–48) 11.7 ± 3.2 (2–36) 0.580
CSA (mm2) (SE) 13.9 ± 0.8 14.3 ± 1.9 0.474
No. of injection (SE) 3.2 ± 0.5 3.0 ± 0.4 0.845
Outcome 0.165
Effective 12 (52.2) 10 (76.9)
Poor 11 (47.8) 3 (23.1)
Other treatment, (%) 6 (26.1) 5 (38.5) 0.475
Follow-up period, (months) (SE) (range) 30.7 ± 3.1 (6–67) 37.2 ± 5.5 (7–62) 0.281

BH = Body height; BW = Body weight; DM = Diabetes mellitus; CSA = Cross-sectional area; SE = standard error. a Mann–Whitney U Test, Fisher’s exact test.